184 related articles for article (PubMed ID: 24982661)
21. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
22. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
[TBL] [Abstract][Full Text] [Related]
23. The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cells.
Nagumo H; Agematsu K; Kobayashi N; Shinozaki K; Hokibara S; Nagase H; Takamoto M; Yasui K; Sugane K; Komiyama A
Blood; 2002 Jan; 99(2):567-75. PubMed ID: 11781240
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of gene transfer with recombinant adeno-associated virus (rAAV) vectors into primary B-cell chronic lymphocytic leukemia cells by CpG-oligodeoxynucleotides.
Theiss HD; Kofler DM; Büning H; Aldenhoff AL; Kaess B; Decker T; Baumert J; Hallek M; Wendtner CM
Exp Hematol; 2003 Dec; 31(12):1223-9. PubMed ID: 14662328
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.
Matolcsy A; Casali P; Nádor RG; Liu YF; Knowles DM
Blood; 1997 Mar; 89(5):1732-9. PubMed ID: 9057657
[TBL] [Abstract][Full Text] [Related]
26. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
Front Immunol; 2018; 9():1996. PubMed ID: 30271400
[TBL] [Abstract][Full Text] [Related]
27. Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients.
Karagiannis P; Correa I; Chauhan J; Cheung A; Dominguez-Rodriguez D; Terranova-Barberio M; Harris RJ; Crescioli S; Spicer J; Bokemeyer C; Lacy KE; Karagiannis SN
Clin Exp Immunol; 2022 Jan; 207(1):84-94. PubMed ID: 35020866
[TBL] [Abstract][Full Text] [Related]
28. Requirement of 8-mercaptoguanosine as a costimulus for IL-4-dependent mu to gamma1 class switch recombination in CD38-activated B cells.
Tsukamoto Y; Uehara S; Mizoguchi C; Sato A; Horikawa K; Takatsu K
Biochem Biophys Res Commun; 2005 Oct; 336(2):625-33. PubMed ID: 16143305
[TBL] [Abstract][Full Text] [Related]
29. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.
Ozcan E; Rauter I; Garibyan L; Dillon SR; Geha RS
J Allergy Clin Immunol; 2011 Sep; 128(3):601-9.e1-4. PubMed ID: 21741080
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
[TBL] [Abstract][Full Text] [Related]
33. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process.
Patten PE; Ferrer G; Chen SS; Simone R; Marsilio S; Yan XJ; Gitto Z; Yuan C; Kolitz JE; Barrientos J; Allen SL; Rai KR; MacCarthy T; Chu CC; Chiorazzi N
JCI Insight; 2016 Apr; 1(4):. PubMed ID: 27158669
[TBL] [Abstract][Full Text] [Related]
37. Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2003 Jan; 70(1):53-9. PubMed ID: 12631259
[TBL] [Abstract][Full Text] [Related]
38. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
[TBL] [Abstract][Full Text] [Related]
39. Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.
Grube M; Rezvani K; Wiestner A; Fujiwara H; Sconocchia G; Melenhorst JJ; Hensel N; Marti GE; Kwak LW; Wilson W; Barrett JA
Clin Cancer Res; 2004 Feb; 10(3):1047-56. PubMed ID: 14871984
[TBL] [Abstract][Full Text] [Related]
40. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
Carpenter EL; Mick R; Rüter J; Vonderheide RH
J Transl Med; 2009 Nov; 7():93. PubMed ID: 19906293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
